
Pharmaceutical Marketing Market by Category (Conference Marketing, PPC Advertising, Print Advertising), Distribution (Generic Drug Marketing, Institutional Supply, Online Pharmacies), Business Model - Global Forecast 2024-2030
Description
Pharmaceutical Marketing Market by Category (Conference Marketing, PPC Advertising, Print Advertising), Distribution (Generic Drug Marketing, Institutional Supply, Online Pharmacies), Business Model - Global Forecast 2024-2030
The Pharmaceutical Marketing Market size was estimated at USD 41.19 billion in 2023 and expected to reach USD 46.03 billion in 2024, at a CAGR 12.26% to reach USD 92.55 billion by 2030.
Global Pharmaceutical Marketing Market
The pharmaceutical market, comprising the discovery, development, production, and distribution of a wide array of medicinal products for human use, is experiencing significant growth due to various factors. These include an increase in chronic diseases worldwide, advancements in medical sciences leading to innovative drug discoveries, favorable government policies encouraging investments in R&D activities, and strategic collaborations between pharmaceutical and biotechnology firms. Notable opportunities contributing to this industry's growth involve personalized medicine based on genetic information for targeted therapies; expansion into emerging markets with rapidly growing economies; digital transformation initiatives such as telemedicine services and electronic health records; adoption of artificial intelligence (AI) and machine learning (ML) tools in drug discovery processes; and increased focus on developing new vaccines to tackle global infectious diseases. However, the industry faces certain limitations and challenges such as stringent regulatory environments potentially delaying product approvals or imposing marketing restrictions on new drugs. Additionally, high costs associated with drug discovery and development can result in pricing pressures affecting patient accessibility. Counterfeit medicines pose a significant threat to patient safety and tarnish the reputation of genuine pharmaceutical products. However, growing concerns over drug-resistant pathogens necessitate continuous innovation in antibiotic research, which further facilitates the marketing need of pharmaceutical products.
Regional Insights
The U.S. signifies its dominance in the global pharmaceutical market due to its large population, high per capita healthcare spending, and robust intellectual property laws that encourage innovation. While Canada's pharmaceutical sector is smaller in comparison to the US market, it is noted for its focus on biopharmaceutical research and development. In Europe, the EU has heavily invested in research initiatives such as Horizon 2020 to foster innovation by funding projects that address major health challenges. In the EMEA region, Middle Eastern markets are experiencing increased demand for branded drugs due to the rising prevalence of diabetes and cardiovascular disorders as lifestyle diseases. Governments within this region aim to boost local pharma landscapes through investments in manufacturing facilities and education programs for local talent. Africa holds untapped potential with countries in South Africa, Nigeria, and Kenya leading pharmaceutical spending while focusing on infectious diseases such as HIV/AIDS, malaria, tuberculosis, and others. Government initiatives toward health improvement in the Asia-Pacific region, particularly in China, India, Japan, Australia actively promoted innovation through incentives for new drug development. Moreover, constant monitoring of patents, research developments, investment trends, and strategic initiatives is expected to aid in identifying growth opportunities worldwide within the pharmaceutical marketing landscape.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Pharmaceutical Marketing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pharmaceutical Marketing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Pharmaceutical Marketing Market, highlighting leading vendors and their innovative profiles. These include Amgen Inc., AstraZeneca PLC, Biogen Inc., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Company, Eli Lilly & Company, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Ltd..
Market Segmentation & Coverage
This research report categorizes the Pharmaceutical Marketing Market to forecast the revenues and analyze trends in each of the following sub-markets:
Category
Conference Marketing
PPC Advertising
Print Advertising
Social Media Campaigns
TV Commercials
Website Pages & Campaigns
Distribution
Generic Drug Marketing
Institutional Supply
Online Pharmacies
OTC (Over The Counter) Marketing
PCD Pharma Franchise
Business Model
B2B
B2C
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Pharmaceutical Marketing Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pharmaceutical Marketing Market?
3. What are the technology trends and regulatory frameworks in the Pharmaceutical Marketing Market?
4. What is the market share of the leading vendors in the Pharmaceutical Marketing Market?
5. Which modes and strategic moves are suitable for entering the Pharmaceutical Marketing Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
198 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Pharmaceutical Marketing Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rise in pharmaceutical research and the need to increase product access
- 5.1.1.2. Need for leveraging pharmaceutical product positioning and pricing
- 5.1.1.3. Rise in drug approvals by regulatory bodies
- 5.1.2. Restraints
- 5.1.2.1. Substantial cost of pharmaceutical marketing
- 5.1.3. Opportunities
- 5.1.3.1. Integration of digital tools in pharmaceutical marketing
- 5.1.3.2. Shift towards a value-based and personalized approach
- 5.1.4. Challenges
- 5.1.4.1. Problems associated with misleading marketing and strict regulatory environment
- 5.2. Market Segmentation Analysis
- 5.2.1. Category: Website pages & campaigns are crucial in pharmaceutical marketing strategies for commercializing pharma product
- 5.2.2. Distribution: PCD pharma franchises enable rapid market expansion for over-all pharmaceutical companies
- 5.2.3. Business Model: B2B marketing emphasize more technical approach to meet the high standards set by regulatory agencies while providing valuable healthcare solutions
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Pharmaceutical Marketing Market, by Category
- 6.1. Introduction
- 6.2. Conference Marketing
- 6.3. PPC Advertising
- 6.4. Print Advertising
- 6.5. Social Media Campaigns
- 6.6. TV Commercials
- 6.7. Website Pages & Campaigns
- 7. Pharmaceutical Marketing Market, by Distribution
- 7.1. Introduction
- 7.2. Generic Drug Marketing
- 7.3. Institutional Supply
- 7.4. Online Pharmacies
- 7.5. OTC (Over The Counter) Marketing
- 7.6. PCD Pharma Franchise
- 8. Pharmaceutical Marketing Market, by Business Model
- 8.1. Introduction
- 8.2. B2B
- 8.3. B2C
- 9. Americas Pharmaceutical Marketing Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Pharmaceutical Marketing Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Pharmaceutical Marketing Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 12.3.1. Merger & Acquisition
- 12.3.1.1. Sun Pharma Completes Acquisition of Concert Pharmaceuticals
- 12.3.2. Agreement, Collaboration, & Partnership
- 12.3.2.1. Two New Partnerships For The Pharmaceutical Industry
- 12.3.3. Award, Recognition, & Expansion
- 12.3.3.1. JB Chemicals Gets USFDA Approval For Generic Drug Marketing
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Amgen Inc.
- 13.1.2. AstraZeneca PLC
- 13.1.3. Biogen Inc.
- 13.1.4. Boehringer Ingelheim International GmbH
- 13.1.5. Bristol Myers Squibb Company
- 13.1.6. Eli Lilly & Company
- 13.1.7. F. Hoffmann-La Roche AG
- 13.1.8. GlaxoSmithKline PLC
- 13.1.9. Merck & Co. Inc.
- 13.1.10. Novartis AG
- 13.1.11. Novo Nordisk A/S
- 13.1.12. Pfizer Inc.
- 13.1.13. Sanofi S.A.
- 13.1.14. Takeda Pharmaceutical Company Limited
- 13.1.15. Teva Pharmaceutical Industries Ltd.
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. PHARMACEUTICAL MARKETING MARKET RESEARCH PROCESS
- FIGURE 2. PHARMACEUTICAL MARKETING MARKET SIZE, 2023 VS 2030
- FIGURE 3. PHARMACEUTICAL MARKETING MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. PHARMACEUTICAL MARKETING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. PHARMACEUTICAL MARKETING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. PHARMACEUTICAL MARKETING MARKET DYNAMICS
- FIGURE 7. PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2023 VS 2030 (%)
- FIGURE 8. PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
- FIGURE 10. PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2023 VS 2030 (%)
- FIGURE 12. PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS PHARMACEUTICAL MARKETING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS PHARMACEUTICAL MARKETING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES PHARMACEUTICAL MARKETING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES PHARMACEUTICAL MARKETING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC PHARMACEUTICAL MARKETING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC PHARMACEUTICAL MARKETING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MARKETING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MARKETING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. PHARMACEUTICAL MARKETING MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. PHARMACEUTICAL MARKETING MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.